Template:Congestive heart failure: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 155: | Line 155: | ||
Medical Therapy: | Medical Therapy: | ||
: [[Congestive heart failure acute pharmacotherapy|Acute Pharmacotherapy]] | : [[Congestive heart failure acute pharmacotherapy|Acute Pharmacotherapy]] | ||
: [[Congestive heart failure chronic pharmacotherapy]] | : [[Congestive heart failure chronic pharmacotherapy|Chronic Pharmacotherapy]] | ||
:: [[Congestive heart failure diuretics|Diuretics]] | :: [[Congestive heart failure classification#Classification of Heart Failure Based on the Ejection Fraction (EF)|HFpEF]]: | ||
:: [[Congestive heart failure ACE inhibitors|ACE Inhibitors]] | :: [[Congestive heart failure classification#Classification of Heart Failure Based on the Ejection Fraction (EF)|HFrEF]]: | ||
:: [[Congestive heart failure angiotensin receptor blockers|Angiotensin receptor blockers]] | ::: [[Congestive heart failure diuretics|Diuretics]] | ||
:: [[Congestive heart failure aldosterone antagonists|Aldosterone Antagonists]] | ::: [[Congestive heart failure ACE inhibitors|ACE Inhibitors]] | ||
:: [[Congestive heart failure beta blockers|Beta Blockers]] | ::: [[Congestive heart failure angiotensin receptor blockers|Angiotensin receptor blockers]] | ||
:: [[Congestive heart failure calcium channel blockers|Ca Channel Blockers]] | ::: [[Congestive heart failure aldosterone antagonists|Aldosterone Antagonists]] | ||
:: [[Congestive heart failure vasodilators|Nitrates]] | ::: [[Congestive heart failure beta blockers|Beta Blockers]] | ||
:: [[Congestive heart failure vasodilators|Hydralazine]] | ::: [[Congestive heart failure calcium channel blockers|Ca Channel Blockers]] | ||
:: [[Congestive heart failure positive inotropics|Positive Inotropics]] | ::: [[Congestive heart failure vasodilators|Nitrates]] | ||
:: [[Congestive heart failure anticoagulants|Anticoagulants]] | ::: [[Congestive heart failure vasodilators|Hydralazine]] | ||
:: [[Congestive heart failure angiotensin receptor-neprilysin inhibitor|Angiotensin Receptor-Neprilysin Inhibitor]] | ::: [[Congestive heart failure positive inotropics|Positive Inotropics]] | ||
:: [[Congestive heart failure antiarrhythmic Drugs|Antiarrhythmic Drugs]] | ::: [[Congestive heart failure anticoagulants|Anticoagulants]] | ||
:: [[Congestive heart failure other pharmacotherapies#Nutritional Supplements|Nutritional Supplements]] | ::: [[Congestive heart failure angiotensin receptor-neprilysin inhibitor|Angiotensin Receptor-Neprilysin Inhibitor]] | ||
:: [[Congestive heart failure other pharmacotherapies#Hormonal Therapies|Hormonal Therapies]] | ::: [[Congestive heart failure antiarrhythmic Drugs|Antiarrhythmic Drugs]] | ||
::: [[Congestive heart failure other pharmacotherapies#Nutritional Supplements|Nutritional Supplements]] | |||
::: [[Congestive heart failure other pharmacotherapies#Hormonal Therapies|Hormonal Therapies]] | |||
:[[Congestive heart failure drugs to avoid|Drugs to Avoid]] | :[[Congestive heart failure drugs to avoid|Drugs to Avoid]] | ||
:[[Congestive heart failure drug interactions|Drug Interactions]] | :[[Congestive heart failure drug interactions|Drug Interactions]] |
Revision as of 14:49, 27 October 2016
Congestive Heart Failure Microchapters |
Differentiating Congestive heart failure from other Diseases |
---|
Diagnosis |
Treatment |
Medical Therapy: |
Surgical Therapy: |
ACC/AHA Guideline Recommendations
|
Specific Groups: |
Congestive heart failure On the Web |
Risk calculators and risk factors for Congestive heart failure |